Annual ROE
-258.44%
-191.83%-287.99%
December 31, 2023
Summary
- As of February 12, 2025, DYN annual return on equity is -258.44%, with the most recent change of -191.83% (-287.99%) on December 31, 2023.
- During the last 3 years, DYN annual ROE has fallen by -241.08% (-1388.71%).
- DYN annual ROE is now -362.08% below its all-time high of 98.61%, reached on December 31, 2018.
Performance
DYN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-57.46%
+11.39%+16.54%
September 30, 2024
Summary
- As of February 12, 2025, DYN quarterly return on equity is -57.46%, with the most recent change of +11.39% (+16.54%) on September 30, 2024.
- Over the past year, DYN quarterly ROE has increased by +11.39% (+16.54%).
- DYN quarterly ROE is now -171.68% below its all-time high of -21.15%, reached on September 30, 2020.
Performance
DYN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DYN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -288.0% | +16.5% |
| 3 y3 years | -1388.7% | +27.8% |
| 5 y5 years | -362.1% | +27.8% |
DYN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -537.3% | at low | -64.8% | +57.9% |
| 5 y | 5-year | -1388.7% | at low | -171.7% | +57.9% |
| alltime | all time | -362.1% | at low | -171.7% | +57.9% |
Dyne Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -57.46%(-16.5%) |
| Jun 2024 | - | -68.85%(-37.9%) |
| Mar 2024 | - | -110.92%(-18.7%) |
| Dec 2023 | -258.44%(+288.0%) | -136.35%(+39.7%) |
| Sep 2023 | - | -97.57%(+22.5%) |
| Jun 2023 | - | -79.63%(+16.2%) |
| Mar 2023 | - | -68.55%(+14.7%) |
| Dec 2022 | -66.61% | -59.74%(+2.4%) |
| Sep 2022 | - | -58.34%(+12.5%) |
| Jun 2022 | - | -51.86%(+27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -40.70%(+16.8%) |
| Dec 2021 | -40.55%(+133.6%) | -34.86%(+16.5%) |
| Sep 2021 | - | -29.91%(+25.8%) |
| Jun 2021 | - | -23.78%(+2.5%) |
| Mar 2021 | - | -23.19%(+9.5%) |
| Dec 2020 | -17.36%(-83.6%) | -21.18%(+0.1%) |
| Sep 2020 | - | -21.15%(-44.9%) |
| Jun 2020 | - | -38.41%(-71.9%) |
| Mar 2020 | - | -136.51%(+70.0%) |
| Dec 2019 | -105.86%(-207.4%) | -80.32% |
| Dec 2018 | 98.61% | - |
FAQ
- What is Dyne Therapeutics annual return on equity?
- What is the all time high annual ROE for Dyne Therapeutics?
- What is Dyne Therapeutics annual ROE year-on-year change?
- What is Dyne Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly ROE year-on-year change?
What is Dyne Therapeutics annual return on equity?
The current annual ROE of DYN is -258.44%
What is the all time high annual ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high annual return on equity is 98.61%
What is Dyne Therapeutics annual ROE year-on-year change?
Over the past year, DYN annual return on equity has changed by -191.83% (-287.99%)
What is Dyne Therapeutics quarterly return on equity?
The current quarterly ROE of DYN is -57.46%
What is the all time high quarterly ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly return on equity is -21.15%
What is Dyne Therapeutics quarterly ROE year-on-year change?
Over the past year, DYN quarterly return on equity has changed by +11.39% (+16.54%)